Literature DB >> 28839741

Variations in surgical management from a national bowel cancer screening programme.

R J Codd1, R Thomas2, H Heard3, A G Radcliffe3, G L Williams2,4, M D Evans1,2.   

Abstract

OBJECTIVE: Population screening for colorectal cancer (CRC) was introduced to Wales in October 2008. The aim of this study was to evaluate the early impact of screening on CRC services.
DESIGN: Prospectively collected data from the Bowel Screening Wales (BSW) programme and the Welsh Bowel Cancer Audit (WBCA) were used to identify all screen-detected (SD) CRC diagnoses in Wales between April 2009 and March 2011. Data from the WBCA were used to calculate surgical outcomes.
RESULTS: 444 SD cancers were registered during the study period representing 11% of all CRC diagnoses. There was a 9.9% increase in CRC incidence following the introduction of the BSW. SD patients presented with earlier stage disease; SD Dukes' A 35.1% vs 13.9% symptomatic patients (p<0.001) and SD Dukes' D 7.4% vs 21.8% symptomatic, (p<0.001). There were more colonic cancers among the SD population (p<0.001). The resection rate for SD cancers was 89%, significantly higher than symptomatic cancers (67.7%; p<0.0001). There was variability in the use of polypectomy as a definitive procedure to treat CRC between units. Overall laparoscopic resection was used in 52% of cases but with considerable interunit variability (0-92%).
CONCLUSIONS: The introduction of screening has increased the workload of the colorectal multidisciplinary teams in Wales. This has occurred through both an increase in case volume and the identification of more patients with early stage disease. There is considerable interunit variability in the use of techniques of local excision and rates of laparoscopic resection that need to be addressed.

Entities:  

Keywords:  Audit; Colorectal Cancer; Colorectal Cancer Screening; Screening

Year:  2013        PMID: 28839741      PMCID: PMC5369829          DOI: 10.1136/flgastro-2013-100335

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  9 in total

1.  Learning the hard way: the importance of accurate data.

Authors:  R S Lewis; D G Graham; J D Watson; P J Lunniss
Journal:  Colorectal Dis       Date:  2012-08       Impact factor: 3.788

2.  Management and short-term outcome of malignant colorectal polyps in the north of England(1).

Authors:  M D Gill; M D Rutter; S J Holtham
Journal:  Colorectal Dis       Date:  2013-02       Impact factor: 3.788

3.  Impact of the bowel-screening programme on the diagnosis of colorectal cancer in Ayrshire and Arran.

Authors:  C S D Roxburgh; F McTaggart; M Balsitis; R H Diament
Journal:  Colorectal Dis       Date:  2013-01       Impact factor: 3.788

4.  Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit.

Authors:  J Mella; A Biffin; A G Radcliffe; J D Stamatakis; R J Steele
Journal:  Br J Surg       Date:  1997-12       Impact factor: 6.939

5.  Survival outcome of patients with screening versus symptomatically detected colorectal cancers.

Authors:  R Pande; P Froggatt; P Baragwanath; C Harmston
Journal:  Colorectal Dis       Date:  2013-01       Impact factor: 3.788

6.  A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.

Authors:  B Towler; L Irwig; P Glasziou; J Kewenter; D Weller; C Silagy
Journal:  BMJ       Date:  1998-08-29

7.  A comparative study of colorectal surgical outcome in a national audit separated by 15 years.

Authors:  M D Evans; R Thomas; G L Williams; J Beynon; J J Smith; J D Stamatakis; B M Stephenson
Journal:  Colorectal Dis       Date:  2013-05       Impact factor: 3.788

8.  Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom.

Authors: 
Journal:  BMJ       Date:  2004-07-05

9.  Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.

Authors:  Richard F A Logan; Julietta Patnick; Claire Nickerson; Lynn Coleman; Matt D Rutter; Christian von Wagner
Journal:  Gut       Date:  2011-12-07       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.